Same Indication

Brexucabtagene Autoleucel vs Methotrexate

## Brexucabtagene Autoleucel vs Methotrexate: Overview

This comparison examines the pharmacological differences between **Brexucabtagene Autoleucel** and **Methotrexate**.

## Mechanism of Action

**Methotrexate**: Dihydrofolate reductase inhibitor.

## Pharmacokinetics

**Half-life**: Brexucabtagene Autoleucel — N/A; Methotrexate — 3-10 hours.

## Chemical Properties

**Molecular Formula**: Brexucabtagene Autoleucel — N/A; Methotrexate — C20H22N8O5.

**Molecular Weight**: Brexucabtagene Autoleucel — N/A; Methotrexate — 454.4400 g/mol.

**Type**: Brexucabtagene Autoleucel — Gene; Methotrexate — Small molecule.